What new Dupilumab data suggest about long-term immune control in allergic disease at Regeneron Pharmaceuticals
Ryerson Holding (NYSE: RYI) finalises Olympic Steel acquisition as North American metals consolidation accelerates
Read More 6 minute read Hotel and Hospitality Restaurant Industry News Whitbread plc (LON: WTB) lifts FY26 outlook as RevPAR outperformance continues in UK and Germany Whitbread plc posted strong RevPAR gains in Q3 FY26 and lifted cost-saving targets. Find out why investors are watching the April Five-Year Plan update. bySrinathJanuary 13, 2026